Search results
Results from the WOW.Com Content Network
The National Health and Medical Research Council (NHMRC) is the main statutory authority of the Australian Government responsible for medical research. It was the eighth largest research funding body in the world in 2016, [ 1 ] and NHMRC-funded research is globally recognised for its high quality. [ 2 ]
Some grants are specified for "new investigators", which is defined as someone who has not received a prior NIH grant other than a career award or specific small grants (R15, R21, R56, etc.). An "early stage investigator" is someone who has received their PhD or MD or has finished residency within the past 10 years. [5]
HHMI spends about $1 million per HHMI Investigator per year, which amounts to annual investment in biomedical research of about $825 million. The institute has an endowment of $22.6 billion , making it the second-wealthiest philanthropic organization in the United States and the second-best-endowed medical research foundation in the world. [ 6 ]
He has held continuous research funding from the National Health and Medical Research Council (NHMRC) since 1985, mostly relating to papilloma viruses or tumor immunology. He is currently a joint Chief Investigator on an NHMRC program grant and a NHMRC/Wellcome program grant, together worth more than $2 million a year.
Clinical researchers are paid in the form of "grants" which are processed when certain milestones are achieved. The grants are typically negotiated prior to study start up. Most clinical trial portals include a secure document exchange technology that facilitates the negotiation of these grants as well as an application that tracks the ...
In drug development and medical device development [1] the Investigator's Brochure (IB) is a comprehensive document summarizing the body of information about an investigational product ("IP" or "study drug") obtained during a drug trial. The IB is a document of critical importance throughout the drug development process and is updated with new ...
Research funding is a term generally covering any funding for scientific research, in the areas of natural science, technology, and social science.Different methods can be used to disburse funding, but the term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and only the most promising receive funding.
In many countries, the term principal investigator (PI) refers to the holder of an independent grant and the lead researcher for the grant project, usually in the sciences, such as a laboratory study or a clinical trial. The phrase is also often used as a synonym for "head of the laboratory" or "research group leader".